Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy

10.7326/0003-4819-111-9-723

10.1016/0140-6736(91)93379-N

10.1016/S0162-3109(00)00188-0

10.1016/0016-5085(90)91027-4

10.1056/NEJM199406023302203

10.1007/s002770050223

Baronci C., 1998, Treatment of acute idiopathic thrombocytopenic purpura in children. A retrospective evaluation of 120 cases, Annali Dell Istituto Superiore di Sanita, 34, 457

10.1159/000204474

10.1136/bmj.312.7028.430

Beardsley D.S., 1998, Nathan and Oski's Hematology of Infancy and Childhood

10.1097/00000539-199708000-00025

10.1182/blood.V71.4.1165.1165

10.1159/000204251

Berchtold P., 1989, Therapy of chronic idiopathic thrombocytopenic purpura in adults, Blood, 74, 2309, 10.1182/blood.V74.7.2309.2309

Berchtold P., 1993, Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment, Blood, 81, 1246, 10.1182/blood.V81.5.1246.1246

Blanchette V., 1998, Management of chronic immune thrombocytopenic purpura in children and adults, Seminars in Hematology, 35, 36

10.1016/S0140-6736(94)92205-5

10.1016/S0022-3476(05)80400-7

10.1016/S0029-7844(98)00390-1

10.1054/cupe.2002.0302

10.1016/S0140-6736(97)04143-3

Bolton‐Maggs P.H.B., 2001, National audit of the management of childhood idiopathic thrombocytopenic purpura against UK guidelines: closing the loop – education and re‐audit demonstrate a change in practice, Blood, 98, 58b

10.1055/s-2001-15256

10.1016/S0022-3476(97)70304-4

10.1111/j.1365-2141.1986.tb02239.x

10.1136/bmj.296.6617.249-a

Bouroncle B.A., 1969, Treatment of refractory idiopathic thrombocytopenic purpura, Journal of the Americal Medical Association, 207, 2049, 10.1001/jama.1969.03150240069006

Brighton T.A., 1996, Prospective evaluation of the clinical usefulness of an antigen‐ specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias, Blood, 88, 194, 10.1182/blood.V88.1.194.194

10.1111/j.1365-2141.1988.tb02492.x

10.1055/s-2001-15257

10.1097/00043426-198424000-00001

Buchanan G.R., 1997, Acute idiopathic thrombocytopenic purpura – management in childhood, Blood, 89, 1464, 10.1182/blood.V89.4.1464

10.1056/NEJM198807213190304

10.1016/0002-9378(90)90996-K

Burrows R.F., 1992, D. Forbes

10.1056/NEJM199311113292005

10.1016/S0889-8588(18)30512-4

10.1111/j.1365-2141.1984.tb01266.x

10.1182/blood.V77.9.1884.1884

10.1016/0140-6736(91)92228-T

10.1055/s-0038-1648202

10.1046/j.1537-2995.1988.28188127949.x

10.1046/j.1365-2141.1998.00568.x

10.1001/archpedi.152.4.345

Carcao M.D., 1998, Short‐course oral prednisone therapy in children presenting with acute immune thrombocytopenic purpura (ITP), Acta Paediatrica Suppl., 424, 71, 10.1111/j.1651-2227.1998.tb01239.x

10.1016/0002-9343(86)90664-9

10.1111/j.1365-2141.1995.tb05326.x

10.1681/ASN.V8111788

CDC, 1993, Recommendations of the advisory committee on immunization practices: use of vaccines and immune globulins in persons with altered immunocompetence, Morbidity and Mortality Weekly Report, 42, 1

10.1097/00043426-199711000-00007

10.1007/BF02067017

10.1016/1040-8428(94)00160-U

10.1111/j.1471-0528.1990.tb02443.x

10.1001/archinte.160.11.1630

Collins P.W., 1992, Treatment modalities of autoimmune blood disorders, Seminars in Hematology, 29, 64

10.1002/(SICI)1096-8652(199801)57:1<85::AID-AJH16>3.0.CO;2-8

10.1056/NEJM199708073370612

Dickerhoff R., 1994, Thrombocytopenia in Childhood

10.1067/mpd.2000.110123

10.1182/blood.V98.7.2282

10.7326/0003-4819-53-5-861

10.1111/j.1365-2141.1987.tb06922.x

Duhem C., 1994, Side‐effects of intravenous immune globulins, Clinical and Experimental Immunology, 97, 79

10.1056/NEJM199201093260206

10.1136/adc.67.8.1056

10.1046/j.1365-2141.1996.4871026.x

10.1182/blood.V97.3.812

10.1016/0022-3468(72)90006-1

Erkman J., 1972, Azathioprine therapy complicated by pregnancy, Obstetrics and Gynecology, 40, 708

10.1002/ajh.2830410308

10.1016/S0140-6736(95)90471-9

10.1056/NEJM199304293281703

Gaines A.R., 2000, Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rh (o) (D) immune globulin intravenous administration in immune thrombocytopenic purpura patients, Blood, 95, 2523, 10.1182/blood.V95.8.2523

10.1136/adc.76.6.522

10.1016/S0140-6736(05)60004-9

Geha R.S., 1996, Therapeutic Immunology

George J.N., 1998, Idiopathic thrombocytopenic purpura: a concise summary of the pathophysiology and diagnosis in children and adults, Seminars in Hematology, 35, 5

10.1056/NEJM199411033311807

10.3109/07853899808999383

George J.N., 1996, Idiopathic thrombocytopenic purpura. a practice guideline developed by explicit methods for the American Society of Hematology, Blood, 88, 3, 10.1182/blood.V88.1.3.3

Gereige R.S., 2000, Treatment of childhood acute immune thrombocytopenic purpura with high‐ dose methylprednisolone, intravenous immunoglobulin, or the combination of both, Puerto Rico Health Sciences Journal, 19, 15

10.1016/S0950-3536(98)80054-1

10.1182/blood.V82.5.1415.1415

10.1046/j.1365-2141.1997.412687.x

10.1016/S0959-289X(99)80133-2

10.1111/j.1471-0528.1997.tb10931.x

Halperin D.S., 1988, Is bone marrow examination justified in idiopathic thrombocytopenic purpura?, American Journal of Diseases of Children, 142, 508

Harrington W.J., 1951, Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura, Journal of Laboratory and Clinical Medicine, 38, 1

10.1111/j.1651-2227.1997.tb08876.x

10.1111/j.1365-2141.1995.tb05179.x

10.1046/j.1365-2141.2002.03430.x

10.1016/S0140-6736(85)90400-3

10.1007/s002770000219

10.1016/0002-9343(94)90048-5

10.1046/j.1365-2141.2001.03194.x

Jim R.T., 1986, Therapeutic use of colchicine in thrombocytopenia, Hawaii Medical Journal, 45, 225

10.1046/j.1365-2141.2001.02893.x

10.1016/S0140-6736(96)12118-8

10.1016/S0022-3476(97)70355-X

10.1111/j.1365-2141.1989.tb06281.x

10.1016/0020-7292(82)90041-8

10.1046/j.1365-2141.2002.03612.x

10.1016/S0022-3476(97)70305-6

10.1056/NEJM199705223362104

10.1212/WNL.50.4.1160

Letsky E.A., 1996, Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology, British Journal of Haematology, 95, 21

Lichtin A., 1996, The ITP practice guideline: what, why, and for whom?, Blood, 88, 1, 10.1182/blood.V88.1.1.1

10.1136/adc.71.3.251

10.3109/08880019709028768

10.1111/j.1365-2141.1999.01409.x

10.1053/beha.2000.0089

10.1111/j.1365-2141.1993.tb03117.x

10.1016/S0140-6736(05)61187-7

10.1046/j.1365-2257.2000.00340.x

10.1136/bmj.308.6921.131b

10.1111/j.1365-2141.1991.tb04513.x

10.1046/j.1537-2995.1981.21381201800.x

10.1016/0140-6736(90)90701-6

10.1056/NEJM198105073041904

10.7326/0003-4819-126-4-199702150-00007

10.1136/bmj.307.6916.1372

10.1136/adc.84.3.227

10.1111/j.1365-2141.1980.tb05942.x

10.1016/0002-9378(76)90637-2

10.1046/j.1365-2141.1997.832723.x

10.1159/000204523

10.1016/0002-9378(90)90674-V

10.1034/j.1600-0609.2000.90166.x

10.1111/j.1600-0609.1989.tb01466.x

10.3109/08880019309029508

Pegels J.G., 1982, Pseudothrombocytopenia: an immunologic study on platelet antibodies dependent on ethylene diamine tetra‐acetate, Blood, 59, 157, 10.1182/blood.V59.1.157.157

10.1182/blood.V64.6.1179.1179

10.1055/s-0037-1615023

10.1182/blood.V97.9.2549

10.1097/00007890-197604000-00004

Proctor S.J., 1989, Improvement of platelet counts in steroid‐unresponsive idiopathic immune thrombocytopenic purpura after short‐course therapy with recombinant alpha 2b interferon, Blood, 74, 1894, 10.1182/blood.V74.6.1894.1894

10.1111/j.1365-2141.1990.tb02569.x

10.1046/j.1365-2141.1999.01305.x

10.1111/j.1651-2227.1992.tb12175.x

10.1016/S0140-6736(94)91635-7

10.1136/adc.72.2.125

10.1034/j.1600-0412.1998.770303.x

10.1056/NEJM199007263230404

10.1097/00043426-199801000-00007

10.1182/blood.V89.8.2689

Schiavotto C., 1993, Adverse reactions after high‐dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature, Haematologica, 78, 35

10.1007/BF01834386

10.1056/NEJM199710093371515

10.1016/0002-9378(88)90414-0

10.1016/0002-9378(80)90677-8

Shaw K.M., 1966, Prosthetic replacement of the superior vena cava, Journal of the Irish Medical Association, 59, 123

10.2741/sherman

10.1111/j.1471-0528.1985.tb01352.x

10.1046/j.1365-2141.1997.3553169.x

10.1056/NEJM198203253061214

Snyder, Jr H.W., 1992, Experience with protein A‐immunoadsorption in treatment‐resistant adult immune thrombocytopenic purpura, Blood, 79, 2237, 10.1182/blood.V79.9.2237.2237

10.1182/blood.V98.4.952

10.1016/S0002-9343(99)80342-8

Strother S.V., 1984, Colchicine therapy for refractory idiopathic thrombocytopenic purpura, Archives of Internal Medicine, 144, 2198, 10.1001/archinte.1984.04400020110017

10.1055/s-2001-15255

10.1016/S0022-3476(99)70367-7

10.1002/ajh.2830480207

10.1093/clinids/17.5.927

10.1159/000189175

10.1136/adc.59.4.316

10.2165/00003495-199040040-00004

10.1046/j.1365-2141.1999.01218.x

10.1097/00043426-199705000-00004

Waters A.H., 1992, Autoimmune thrombocytopenia: clinical aspects, Seminars in Hematology, 29, 18

10.5694/j.1326-5377.1999.tb140321.x

10.1046/j.1365-2141.2001.03039.x

Woods, Jr V.L., 1984, Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura, Blood, 64, 156, 10.1182/blood.V64.1.156.156

Woods V.L., 1984, Autoantibodies against the platelet glycoprotein IIb/IIIa complex in patients with chronic ITP, Blood, 63, 368, 10.1182/blood.V63.2.368.368

Yang R., 2000, Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update, International Journal of Hematology, 71, 18

10.1080/08880010050122816

10.1016/S0140-6736(05)64068-8